-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US8292141053
ISIN US8292141053
WKN 924294
Symbol SLP
Währung
USD
Zahlte zuletzt am 23.04.2021 eine Dividende von 0,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 0,44 % p. a.
beim aktuellen Kurs von 71,19 USD -2,35%
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 71,19 USD -2,35%
Portrait der Simulations Plus Aktie
Das Unternehmen Simulations Plus aus USA ist im Bereich Softwareservice & -dienstleistungen tätig.
Simulations Plus ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares S&P SmallCap 600 UCITS ETF gewichtet Simulations Plus mit 0,07% im ETF.
6 ETFs die in Simulations Plus investieren
Dir gefallen die Informationen zu Simulations Plus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Simulations Plus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Simulations Plus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Simulations Plus?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
39 News & Informationen zur Simulations Plus Aktie
Conestoga Capital Advisors, LLC Buys Brooks Automation Inc, Vericel Corp, Simulations Plus Inc, Sells RealPage Inc, Bottomline Technologies Inc,
GuruFocus Article or News written by insider and the topic is about:
Biosimulation Market to Grow by USD 2.09 Billion| Key Drivers, Opportunities and Market Forecasts|17000+ Technavio Research Reports |Technavio
/PRNewswire/ — The biosimulation market is poised to grow by USD 2.09 billion during 2021-2025, progressing at a CAGR of 13.17% during the forecast period….
James Investment Research Inc Buys BTC iShares Floating Rate Bond ETF, Invesco Dynamic Leisure and Entertainment ETF, NVIDIA Corp, Sells iShares 3-7 Year Treasury Bond ETF, iShares Intermediate Credit
GuruFocus Article or News written by insider and the topic is about:
Hedge Funds Aren’t Crazy About Kiniksa Pharmaceuticals, Ltd. (KNSA) Anymore
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on…
Where Do Hedge Funds Stand On Vocera Communications Inc (VCRA)?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
Ex-Dividend Reminder: Simulations Plus, Texas Instruments and Brinks
PepsiCo, Nokia rise; Boeing, Conagra fall
Stocks that traded heavily or had substantial price changes Tuesday: PepsiCo, Nokia rise; Boeing, Conagra fall
Here's Why Simulations Plus Stock Is Sliding Today
Investors weren't happy about hiccups that pressured fiscal third-quarter revenue.
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET on Tuesday, 48 companies set new 52-week lows.
Interesting Highlights: Marqeta (NASDAQ:MQ) was the largest company by market …
Simulations Plus (SLP) Q3 Earnings Top, Revenues Miss Estimates
Simulations Plus (SLP) Q3 results are hurt by weakness in Services business, stemming from project delays. Software business revenues witness strong growth.
Simulations Plus declares $0.06 dividend (NASDAQ:SLP)
Simulations Plus (NASDAQ:SLP) declares $0.06/share quarterly dividend, in line with previous.Forward yield 0.45%Payable Aug.
Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript
SLP earnings call for the period ending May 31, 2021.
Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q3 2021 Results – Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP) Q3 2021 Earnings Conference Call July 12, 2021 4:15 PM ET Company Participants Brian Siegel – Hayden IR Shawn O'Connor – CEO Will Frederick – CFO…
A Peek Into The Markets: US Stock Futures Mostly Lower; Crude Oil Down
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones jumped around 450 points on Friday. Investor…
Simulations Plus Q3 2021 Earnings Preview (NASDAQ:SLP)
Simulations Plus (NASDAQ:SLP) is scheduled to announce Q3 earnings results on Monday, July 12th, after market close.The consensus EPS Estimate is $0.18 (+12.5% Y/Y) and the…
Simulations Plus (SLP) to Post Q3 Earnings: What's in Store?
Simulations Plus (SLP) fiscal third-quarter performance is likely to reflect gains from strength in its diversified portfolio that includes offerings like GastroPlus, DDDPlus and PKPlus.
Simulations Plus Celebrates 25 Years In Business
This month marks the 25th anniversary of Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical,
Simulations Plus Celebrates 25 Years in Business
Simulations Plus Celebrates 25 Years in Business | Nachricht | finanzen.net
Earnings Preview: Simulations Plus (SLP) Q3 Earnings Expected to Decline
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Simulations Plus (SLP) Q3 Earnings Expected to Decline
Stocks Analysis by Zacks Investment Research covering: Simulations Plus Inc. Read Zacks Investment Research's latest article on Investing.com
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call | Nachricht | finanzen.net
Simulations Plus Sets Date For Third Quarter Fiscal Year 2021 Earnings Release And Conference Call
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the third quarter of fiscal year 2021, the period ended May
Is Cango Inc. (CANG) A Good Stock To Buy?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
Simulations Plus: Growth, Speculation In Drug Industry (NASDAQ:SLP)
Simulations Plus's total return over-performed the Dow average for my 64 month test period by 471.60%, which is fantastic.
Simulations Plus (SLP) Q2 Earnings & Revenues Top Estimates
Simulations Plus' (SLP) fiscal second-quarter results benefit from strong performance of the company's higher-margin software business.
MÄRKTE USA/Dow leicht im Minus – S&P-500 mit Rekordhoch
MÄRKTE USA/Dow leicht im Minus – S&P-500 mit Rekordhoch | Nachricht | finanzen.net
Simulations Plus, Inc.'s (SLP) CEO Shawn O'Connor on Q2 2021 Results – Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2021 Earnings Conference Call April 12, 2021, 04:15 PM ET Company Participants Jeff Stanlis – Hayden IR Shawn O'Connor – CEO Will Frederick – CFO…
Simulations Plus, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:SLP)
The following slide deck was published by Simulations Plus, Inc.
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
Simulations Plus (SLP) delivered earnings and revenue surprises of 7.14% and 1.68%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus EPS beats by $0.01, beats on revenue (NASDAQ:SLP)
Simulations Plus (SLP): FQ2 GAAP EPS of $0.15 beats by $0.01.Revenue of $13.15M (+27.1% Y/Y) beats by $0.31M.Gross margin was 78%, up from 74%.“While we expect growth to normalize…
Alibaba, Nuance, Microsoft: What to Watch When the Market Opens
S&P 500 futures point to the market opening below last week's record highs
Simulations Plus (SLP) Stock Down Despite Q1 Earnings Beat
Simulations Plus (SLP) fiscal first-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.
Stocks of Note for Jan-12 Morning
Simulations Plus Inc (SLP) Q1 2021 Earnings Call Transcript
SLP earnings call for the period ending November 30, 2020.
Simulations Plus (SLP) Q1 Earnings and Revenues Top Estimates
Simulations Plus (SLP) delivered earnings and revenue surprises of 9.09% and 1.35%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Simulations Plus Q1 Earnings
Shares of Simulations Plus (NASDAQ:SLP) were flat after the company reported Q1 results.
Quarterly Results
Earnings per share increased 9.09% year over year …
Stocks That Hit 52-Week Highs On Friday
This morning 470 companies set new 52-week highs.
Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …
Earnings Outlook For Simulations Plus
Simulations Plus (NASDAQ:SLP) releases its next round of earnings this Monday, January 11. Get the latest predictions in Benzinga's essential guide to …
Simulations Plus (SLP) to Post Q1 Earnings: What’s in Store?
Simulations Plus (SLP) fiscal first-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech industries.